Vitality Watch

Dossier pubmed observational 06-jun-2026
Human cohort, case-control, or epidemiological association

Association between bile acid metabolism and sarcopenia in older adults.

Key claim: Elevated serum 3β-HDCA and GLCA are associated with sarcopenia in older adults, 3β-HDCA tracks slower 6-m gait speed, and TLCA-linked sarcopenia risk is markedly higher in those sleeping more than 8 hours.

Abstract

BACKGROUND: Sarcopenia poses a significant global health challenge, yet its metabolic underpinnings remain incompletely understood. Bile acids (BAs), acting as potent signaling molecules, are increasingly recognized for their role in skeletal muscle homeostasis. However, clinical evidence linking BA metabolic profiles to primary sarcopenia in older adults remains scarce. METHODS: We conducted a matched case-control study utilizing LC-MS/MS-based metabolomics to comprehensively characterize serum BA profiles in older adults with sarcopenia compared to healthy controls. RESULTS: We observed six differential BAs, among which 3β-hyodeoxycholic acid (3β-HDCA) and glycolithocholic acid (GLCA) showed significant elevation in the sarcopenia group compared to controls. In conditional logistic regression analyses, elevated 3β-HDCA levels exhibited an independent association with sarcopenia risk across multiple adjustment models. A combined biomarker model yielded an Area Under the Curve (AUC) of 0.738. Furthermore, 3β-HDCA levels were found to be correlated with physical performance, specifically 6-m gait speed. Notably, interaction analysis indicated that the risk of sarcopenia associated with elevated taurolithocholic acid (TLCA) levels was significantly higher in individuals with long sleep duration (>8 h) (OR = 8.244, P = 0.022). CONCLUSIONS: This study characterizes a distinct BA metabolic profile, identifying elevated 3β-HDCA and GLCA as potential biomarkers for sarcopenia. Moreover, our findings imply a potential interaction between sleep duration and BA metabolism (specifically TLCA) in the context of muscle loss. These observations may provide insights for future preventative strategies and warrant further investigation into the underlying mechanisms.

Why this matters

Most evidence for a bile-acid–muscle axis in aging has been preclinical (BSH-active probiotics in dexamethasone-sarcopenia mice, hepatic ACAT3 knockouts). This matched case-control study is the first human observational signal linking specific circulating bile-acid species to sarcopenia phenotypes and gait speed, moving the axis one tier toward human relevance without establishing causality. The sleep-duration interaction with TLCA also raises the possibility that behavioral/circadian modifiers gate bile-acid effects on muscle.

Source

Link

Briefing card

Association between bile acid metabolism and sarcopenia in older adults.
Stage: observational · pubmed · 06-jun-2026

If you are an older adult being screened for sarcopenia, this study adds specific serum bile acids (3β-HDCA, GLCA) to the list of candidate biomarkers being investigated alongside grip strength and gait speed, with no clinical use established yet.

Elevated serum 3β-HDCA and GLCA are associated with sarcopenia in older adults, 3β-HDCA tracks slower 6-m gait speed, and TLCA-linked sarcopenia risk is markedly higher in those sleeping more than 8 hours.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.cca.2026.121138

build build 880 · 2bcef25 · 2026-11-18